- Home
- ATNF vs SPRC Comparison
ATNF vs SPRC Comparison
Compare ATNF & SPRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATNF
- SPRC
- Stock Information
- Founded
- ATNF 2016
- SPRC 2004
- Country
- ATNF United States
- SPRC Israel
- Employees
- ATNF N/A
- SPRC N/A
- Industry
- ATNF Biotechnology: Pharmaceutical Preparations
- SPRC Biotechnology: Pharmaceutical Preparations
- Sector
- ATNF Health Care
- SPRC Health Care
- Exchange
- ATNF Nasdaq
- SPRC Nasdaq
- Market Cap
- ATNF 2.6M
- SPRC 2.4M
- IPO Year
- ATNF N/A
- SPRC N/A
- Fundamental
- Price
- ATNF $2.25
- SPRC $0.25
- Analyst Decision
- ATNF
- SPRC
- Analyst Count
- ATNF 0
- SPRC 0
- Target Price
- ATNF N/A
- SPRC N/A
- AVG Volume (30 Days)
- ATNF 184.0K
- SPRC 463.0K
- Earning Date
- ATNF 11-14-2024
- SPRC 12-03-2024
- Dividend Yield
- ATNF N/A
- SPRC N/A
- EPS Growth
- ATNF N/A
- SPRC N/A
- EPS
- ATNF N/A
- SPRC N/A
- Revenue
- ATNF N/A
- SPRC $1,747,000.00
- Revenue This Year
- ATNF N/A
- SPRC N/A
- Revenue Next Year
- ATNF $54.15
- SPRC N/A
- P/E Ratio
- ATNF N/A
- SPRC N/A
- Revenue Growth
- ATNF N/A
- SPRC N/A
- 52 Week Low
- ATNF $1.16
- SPRC $0.21
- 52 Week High
- ATNF $17.75
- SPRC $14.22
- Technical
- Relative Strength Index (RSI)
- ATNF 39.56
- SPRC 66.10
- Support Level
- ATNF $2.22
- SPRC $0.22
- Resistance Level
- ATNF $2.45
- SPRC $0.24
- Average True Range (ATR)
- ATNF 0.33
- SPRC 0.02
- MACD
- ATNF -0.15
- SPRC 0.00
- Stochastic Oscillator
- ATNF 9.25
- SPRC 98.10
About ATNF 180 Life Sciences Corp.
180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis by employing innovative research, and, where appropriate, combination therapy.
About SPRC SciSparc Ltd.
SciSparc Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.